- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 215/54 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
Patent holdings for IPC class C07D 215/54
Total number of patents in this class: 276
10-year publication summary
|
20
|
18
|
20
|
21
|
24
|
16
|
19
|
20
|
14
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19857 |
8 |
| Araxes Pharma LLC | 90 |
8 |
| Ono Pharmaceutical Co., Ltd. | 434 |
8 |
| Syngenta Participations AG | 1907 |
7 |
| ClanoTech AB | 10 |
7 |
| Gilead Sciences, Inc. | 2031 |
7 |
| Bayer Animal Health GmbH | 221 |
6 |
| Neurocrine Biosciences, Inc. | 409 |
6 |
| Regenacy Pharmaceuticals, LLC | 26 |
6 |
| Grünenthal GmbH | 574 |
5 |
| Inflarx GmbH | 46 |
5 |
| Bristol-myers Squibb Company | 4879 |
4 |
| Vertex Pharmaceuticals Incorporated | 1595 |
4 |
| Imago Biosciences, Inc. | 38 |
4 |
| Neuronascent, Inc. | 15 |
4 |
| The Research Foundation for The State University of New York | 1612 |
4 |
| Firmenich Incorporated | 148 |
4 |
| Monsanto Technology LLC | 8263 |
3 |
| Kissei Pharmaceutical Co., Ltd. | 187 |
3 |
| Sunshine Lake Pharma Co., Ltd. | 596 |
3 |
| Other owners | 170 |